WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2022

Feb 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2022-02-22

Reporting Person: Favorite Annette F (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-02-22	Stock Options (Right to buy)	$369.13	A	3108.00	Acquired	2032-02-22	Stock Options (Right to Buy) (3108.00)	Direct

Footnotes

F1: This award vests in four equal annual installments beginning on February 22, 2023.